TRA — Supplementary Material
Source: TRA_Revised_Supplementary_Material.docx. Companion material; verify exact correspondence to manuscript version before publication.
Supplementary Material
Temporal Response Architecture (TRA)
Supplementary Methods
Literature identification was domain-driven. Publications were retained when they contributed either direct procedural evidence or mechanistically relevant information to at least one predefined response domain of the Temporal Response Architecture.
Inclusion did not require agreement with the proposed model. Discordant observations were retained when relevant to a predefined domain. Publications describing ocular complications arising through mechanisms outside the predefined pigment-associated anterior-segment and aqueous-outflow scope were not incorporated into the mechanistic architecture but were used to define its boundaries.
Review articles were used primarily for background, terminology, and citation chaining rather than as primary evidence for mechanistic conclusions.
The literature was synthesized within predefined response domains using a focused mechanistic approach. This strategy links direct procedural findings to experimental insights concerning trabecular function, aqueous dynamics, and cellular processing.
Supplementary Table S1. PubMed Search Strategy for the Focused Mechanistic Review
Database: PubMed. Coverage: database inception through 30 September 2026.
Search A — Direct iris-directed laser evidence
("laser iris depigmentation"[Title/Abstract] OR "iris depigmentation"[Title/Abstract] OR "cosmetic iridoplasty"[Title/Abstract] OR "iris color change"[Title/Abstract] OR "iris colour change"[Title/Abstract] OR "iris pigment modification"[Title/Abstract] OR "iris pigmentation"[Title/Abstract]) AND (laser*[Title/Abstract] OR Nd:YAG[Title/Abstract] OR "selective laser trabeculoplasty"[Title/Abstract] OR SLT[Title/Abstract])
Purpose: To identify human clinical reports and direct preclinical studies involving intentional laser modification of iris pigmentation.
Search B — Pigment–trabecular and aqueous-outflow interaction
(pigment*[Title/Abstract] OR "pigment dispersion"[Title/Abstract] OR "pigmentary glaucoma"[Title/Abstract]) AND ("trabecular meshwork"[Title/Abstract] OR "aqueous outflow"[Title/Abstract] OR "outflow facility"[Title/Abstract]) AND (phagocyt*[Title/Abstract] OR migration[Title/Abstract] OR contract*[Title/Abstract] OR cytoskeleton[Title/Abstract] OR "intraocular pressure"[Title/Abstract])
Purpose: To identify evidence concerning the effects of pigment exposure on trabecular cellular behavior and conventional aqueous outflow.
Search C — Laser-associated inflammatory and remodeling responses
("selective laser trabeculoplasty"[Title/Abstract] OR "laser trabeculoplasty"[Title/Abstract] OR SLT[Title/Abstract]) AND (inflammation[Title/Abstract] OR inflammatory[Title/Abstract] OR cytokine*[Title/Abstract] OR "interleukin-1"[Title/Abstract] OR "IL-1"[Title/Abstract] OR "tumor necrosis factor"[Title/Abstract] OR TNF[Title/Abstract] OR "anterior chamber"[Title/Abstract])
Purpose: To identify mechanistically relevant inflammatory, cellular, and matrix-remodeling responses following anterior-segment laser exposure.
Search D — Cellular processing, macrophages, and clearance
("trabecular meshwork"[Title/Abstract] OR "aqueous outflow"[Title/Abstract]) AND (macrophage*[Title/Abstract] OR monocyte*[Title/Abstract] OR phagocyt*[Title/Abstract] OR clearance[Title/Abstract] OR debris[Title/Abstract]) AND (laser[Title/Abstract] OR pigment*[Title/Abstract] OR iridotomy[Title/Abstract])
Purpose: To identify mechanistic evidence concerning particulate processing, phagocytosis, monocyte/macrophage recruitment, and recovery of conventional aqueous outflow.
Supplementary identification: Reference lists of eligible primary studies and relevant reviews were manually screened for additional publications addressing the predefined response domains.
Interpretive note: These searches were intended to support focused mechanistic synthesis and should not be interpreted as a comprehensive systematic search of all literature concerning cosmetic eye-color modification.
Supplementary Table S2. Study-Level Evidence Map and Interpretive Boundaries
Evidence-category definitions: Category A, direct human procedural evidence; Category B, direct preclinical iris evidence; Category C, mechanistically analogous evidence; Category D, integrative inference generated by the present synthesis. Categories reflect biological proximity to the clinical question rather than methodological quality.
Supplementary Table S3. Contextual, Scope-Boundary, and Related Conceptual Literature
Contextual note: L-SAFE, L-OAT, and TRA address complementary dimensions of anterior-segment assessment, phenotyping, and temporal response.
Supplementary table 1 (source order)
| Study | Model and exposure | Observation informing TRA | Response domain | Class |
| Yildirim et al., 2016 | Rabbit iris; Frequency-doubled Nd:YAG iris exposure | Pigment reduction with transient AC cells/flare and no significant IOP change in the reported protocol | Target interaction; inflammatory response | B |
| Basoglu & Celik, 2018 | Human; sectoral heterochromia; 532-nm SLT-platform iris treatment | Human iris-directed treatment using a gradual zonal/staged approach | Target interaction | A |
| Grimaldos Ruiz, 2021 | Human; 1176 eyes; Protocol-specific 532-nm Q-switched Nd:YAG | Cosmetic pigment change; reported longitudinal IOP behavior and inflammatory findings in a subset | Target interaction; IOP response | A |
| Ning et al., 2022 | Human case; Cosmetic iris-lightening laser | Secondary pigment dispersion following treatment | Pigment redistribution | A |
| Ong et al., 2023 | Human case; Cosmetic iris laser | Refractory secondary pigmentary glaucoma | Pigment redistribution; IOP response | A |
| Swampillai et al., 2023 | Human case; Cosmetic iris color-change laser | Secondary pigmentary glaucoma | Pigment redistribution; IOP response | A |
| Liu et al., 2023 | Human case; Multiple cosmetic iris-laser sessions | Severe bilateral IOP elevation with dense pigmented AC findings | Pigment redistribution; IOP response | A |
| Jaber et al., 2026 | Human cases; Procedures described as LID | Marked IOP elevation following cosmetic iris laser treatment | IOP response | A |
| Matsumoto & Johnson, 1997 | Human trabecular tissue; Phagocytic assessment | Active phagocytic capacity of trabecular meshwork cells | Trabecular biology | C |
| Epstein et al., 1986 | Living monkey model; Experimental pigment infusion | Acute reduction in outflow facility followed by recovery and particulate uptake | Outflow disturbance; recovery | C |
| Dang et al., 2018 | Experimental pigmentary-glaucoma model; Pigment exposure | IOP elevation preceding later reduction in trabecular phagocytic activity | Outflow response; temporal relationship | C |
| Wang et al., 2019 | Trabecular-meshwork cellular model; Pigment exposure | Reduced migration and phagocytosis with cytoskeletal and contractile changes | Pigment–trabecular interaction | C |
| De Keyser et al., 2017 | Human SLT; Selective laser trabeculoplasty | Early anterior-chamber cellular response and transient IOP changes | Inflammatory response | C |
| Bradley et al., 2000 | Laser-trabeculoplasty model; Laser exposure | Early IL-1β/TNF-α signaling and matrix-remodeling responses | Inflammatory signaling | C |
| Alvarado et al., 2010 | SLT-related experimental/human outflow work; Selective laser trabeculoplasty | Monocyte/macrophage recruitment and modulation of conventional outflow | Cellular processing; recovery | C |
| Nemoto et al., 2023 | Mouse laser-iridotomy model and TM cells; Laser iridotomy | Pigment/debris accumulation, phagocytic processing, and association between clearance and IOP recovery | Cellular processing; recovery | C |
Supplementary table 2 (source order)
| Source | Literature category | Contribution to TRA context |
| Imesch et al., 1997 | Background biology | Iris morphology and pigmentation |
| Sturm & Larsson, 2009 | Background biology | Iris pigmentation and phenotype |
| D’Oria et al., 2022 | Contextual review | Background on eye-color modification techniques; citation chaining |
| D’Oria & Alio, 2025 | Contextual review | Updated procedural context and citation chaining |
| Ferrari, 2021 | Scope boundary | Demonstrates reported structural iris injury |
| Flores-Márquez et al., 2023 | Scope boundary | Demonstrates posterior-segment laser-associated injury |
| Wisdorf et al., 2025 | Scope boundary | Demonstrates lamellar macular-hole/epiretinal changes |
| Mete, L-SAFE, 2026 | Related conceptual framework | Clinical state and safety-oriented trajectory interpretation |
| Mete, L-OAT, 2026 | Related conceptual framework | Multimodal measurement and iris phenotyping |